The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Autologous peripheral blood stem cell mobilization following high-dose CHOP chemotherapy combined with rituximab in patients with NHL.
Ping Zhou
No relevant relationships to disclose
Yuankai Shi
No relevant relationships to disclose
Xiaohui He
No relevant relationships to disclose
Peng Liu
No relevant relationships to disclose
Xiaohong Han
No relevant relationships to disclose
Shengyu Zhou
No relevant relationships to disclose
Jianliang Yang
No relevant relationships to disclose
Changgong Zhang
No relevant relationships to disclose
Yan Qin
No relevant relationships to disclose
Sheng Yang
No relevant relationships to disclose
Liya Zhao
No relevant relationships to disclose
Jiarui Yao
No relevant relationships to disclose
Shuxiang Zhang
No relevant relationships to disclose
Yan Sun
No relevant relationships to disclose